Literature DB >> 12925357

Nonsteroidal anti-inflammatory drugs protect against Parkinson neurodegeneration: can an NSAID a day keep Parkinson disease away?

Mya Schiess.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12925357     DOI: 10.1001/archneur.60.8.1043

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


× No keyword cloud information.
  13 in total

1.  Temporal mRNA profiles of inflammatory mediators in the murine 1-methyl-4-phenyl-1,2,3,6-tetrahydropyrimidine model of Parkinson's disease.

Authors:  R Pattarini; R J Smeyne; J I Morgan
Journal:  Neuroscience       Date:  2007-01-29       Impact factor: 3.590

Review 2.  Estrogen anti-inflammatory activity in brain: a therapeutic opportunity for menopause and neurodegenerative diseases.

Authors:  Elisabetta Vegeto; Valeria Benedusi; Adriana Maggi
Journal:  Front Neuroendocrinol       Date:  2008-04-29       Impact factor: 8.606

3.  Chronic Brain Inflammation: The Neurochemical Basis for Drugs to Reduce Inflammation.

Authors:  Bevyn Jarrott; Spencer J Williams
Journal:  Neurochem Res       Date:  2015-07-16       Impact factor: 3.996

Review 4.  Inflammasomes link vascular disease with neuroinflammation and brain disorders.

Authors:  Nikolett Lénárt; David Brough; Ádám Dénes
Journal:  J Cereb Blood Flow Metab       Date:  2016-08-02       Impact factor: 6.200

Review 5.  Chaperones and proteases: cellular fold-controlling factors of proteins in neurodegenerative diseases and aging.

Authors:  Marie-Pierre Hinault; Anat Ben-Zvi; Pierre Goloubinoff
Journal:  J Mol Neurosci       Date:  2006       Impact factor: 3.444

6.  Inflammatory cells and cytokines in the olfactory bulb of a rat model of neuroinflammation; insights into neurodegeneration?

Authors:  Marie-Francoise Doursout; Michael S Schurdell; Lauren M Young; Uzondu Osuagwu; Diana M Hook; Brian J Poindexter; Mya C Schiess; Diane L M Bick; Roger J Bick
Journal:  J Interferon Cytokine Res       Date:  2013-04-19       Impact factor: 2.607

Review 7.  Innate and adaptive immunity for the pathobiology of Parkinson's disease.

Authors:  David K Stone; Ashley D Reynolds; R Lee Mosley; Howard E Gendelman
Journal:  Antioxid Redox Signal       Date:  2009-09       Impact factor: 8.401

Review 8.  Targeting microglia-mediated neurotoxicity: the potential of NOX2 inhibitors.

Authors:  Michael J Surace; Michelle L Block
Journal:  Cell Mol Life Sci       Date:  2012-05-13       Impact factor: 9.261

9.  Peripheral inflammation increases the damage in animal models of nigrostriatal dopaminergic neurodegeneration: possible implication in Parkinson's disease incidence.

Authors:  A Machado; A J Herrera; J L Venero; M Santiago; R M De Pablos; R F Villarán; A M Espinosa-Oliva; S Argüelles; M Sarmiento; M J Delgado-Cortés; R Mauriño; J Cano
Journal:  Parkinsons Dis       Date:  2011-04-13

10.  Use of non-steroidal anti-inflammatory drugs and risk of Parkinson's disease: nested case-control study.

Authors:  Jane A Driver; Giancarlo Logroscino; Linda Lu; J Michael Gaziano; Tobias Kurth
Journal:  BMJ       Date:  2011-01-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.